Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA–IIIA non-small-cell lung cancer

被引：4
作者：
Masafumi Kawamura
Keisuke Eguchi
Yotaro Izumi
Yasushi Yamato
Teruaki Koike
Hirozo Sakaguchi
Enjo Hada
Koichi Kobayashi
机构：
[1] Keio University Hospital,Division of General Thoracic Surgery
[2] Niigata Prefectural Cancer Center Hospital,undefined
[3] Mitsui Memorial Hospital,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 60卷
关键词：
Non-platinum doublet; Adjuvant chemotherapy; Non-small-cell lung cancer; Docetaxel; Gemcitabin; Surgery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：495 / 501
页数：6
相关论文
共 50 条
  • [21] A Phase II Study of Adjuvant Chemotherapy with Docetaxel plus Nedaplatin for Completely Resected Non-Small Cell Lung Cancer
    Teramoto, K.
    Namura, Y.
    Hayashi, K.
    Ishida, K.
    Ueda, K.
    Okamoto, K.
    Kaku, R.
    Hori, T.
    Kawaguchi, Y.
    Igarashi, T.
    Hashimoto, M.
    Ohshio, Y.
    Kitamura, S.
    Motoishi, M.
    Suzumura, Y.
    Sawai, S.
    Hanaoka, J.
    Daigo, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1963 - S1964
  • [22] A PILOT STUDY OF NEDAPLATIN PLUS DOCETAXEL AS ADJUVANT CHEMOTHERAPY IN PATIENTS WITH RESECTED NON-SMALL-CELL LUNG CANCER
    Kawaguchi, You
    Hori, Tetsuo
    Kitamura, Shoji
    Teramoto, Koji
    Hanaoka, Jun
    Tezuka, Noriaki
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1582 - S1582
  • [23] Randomized phase II trial of adjuvant chemotherapy with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: TORG 0503
    Kubota, Kaoru
    Kunitoh, Hideo
    Seto, Takashi
    Shimada, Naoki
    Tsuboi, Masahiro
    Ohhira, Tatsuo
    Okamoto, Hiroaki
    Masuda, Noriyuki
    Maruyama, Riichiroh
    Shibuya, Masahiko
    Watanabe, Koshiro
    LUNG CANCER, 2020, 141 : 32 - 36
  • [24] PHASE II TRIAL OF ADJUVANT CHEMOTHERAPY WITH TRI-WEEKLY CARBOPLATIN PLUS DOCETAXEL IN PATIENTS WITH COMPLETELY RESECTED NON-SMALL CELL LUNG CANCER: INTERIM ANALYSIS
    Uramoto, Hidetaka
    Nakanishi, Ryoichi
    Sugaya, Masakazu
    Uchiyama, Akihiko
    Inoue, Masaaki
    Iwata, Teruo
    Ebi, Noriyuki
    Hanagiri, Takeshi
    Tanaka, Fumihiro
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S475 - S475
  • [25] Phase II study of adjuvant vinorelbine and cisplatin in Japanese patients with completely resected stage II and III non-small cell lung cancer
    Makoto Sonobe
    Ken-ichi Okubo
    Satoshi Teramukai
    Kazuhiro Yanagihara
    Masaaki Sato
    Toshihiko Sato
    Fengshi Chen
    Kiyoshi Sato
    Takuji Fujinaga
    Tsuyoshi Shoji
    Mitsugu Omasa
    Hiroaki Sakai
    Ryo Miyahara
    Toru Bando
    Hiroshi Date
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 1199 - 1206
  • [26] A PHASE II TRIAL OF THE COMBINATION OF GEMCITABINE AND CARBOPLATIN AS ADJUVANT CHEMOTHERAPY IN PATIENTS WITH COMPLETELY RESECTED NON-SMALL CELL LUNG CANCER. (KENBYO 0601)
    Muraoka, Masashi
    Akamine, Shinji
    Tsuchiya, Tomoshi
    Morino, Shigeyuki
    Kamohara, Ryotaro
    Mochinaga, Koji
    Shimoyama, Koichiro
    Sengyoku, Hideyori
    Obata, Tomohiro
    Mizoguchi, Satoshi
    Ikuta, Yasushi
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S581 - S581
  • [27] Propensity-matched analysis of adjuvant chemotherapy for completely resected Stage IB non-small-cell lung cancer patients
    Li, Xiao
    Zhang, Chao
    Sun, Zewen
    Yang, Fan
    Xiao, Rongxin
    Sui, Xizhao
    Jiang, Guanchao
    Zhong, Wenzhao
    Wang, Jun
    LUNG CANCER, 2019, 133 : 75 - 82
  • [28] Phase II study of adjuvant vinorelbine and cisplatin in Japanese patients with completely resected stage II and III non-small cell lung cancer
    Sonobe, Makoto
    Okubo, Ken-ichi
    Teramukai, Satoshi
    Yanagihara, Kazuhiro
    Sato, Masaaki
    Sato, Toshihiko
    Chen, Fengshi
    Sato, Kiyoshi
    Fujinaga, Takuji
    Shoji, Tsuyoshi
    Omasa, Mitsugu
    Sakai, Hiroaki
    Miyahara, Ryo
    Bando, Toru
    Date, Hiroshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (06) : 1199 - 1206
  • [29] A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703)
    Shin-ichi Fukumoto
    Satoshi Oizumi
    Masao Harada
    Noriaki Sukoh
    Kosuke Nakano
    Satoshi Fuke
    Jun Sakakibara-Konishi
    Kei Takamura
    Kenichiro Ito
    Yuka Fujita
    Yutaka Nishigaki
    Toshiyuki Harada
    Kenji Akie
    Ichiro Kinoshita
    Toraji Amano
    Hiroshi Isobe
    Hirotoshi Dosaka-Akita
    Masaharu Nishimura
    Cancer Chemotherapy and Pharmacology, 2020, 86 : 117 - 127
  • [30] Adjuvant Therapy in Patients With Completely Resected Non-small-cell Lung Cancer: Current Status and Perspectives
    Pirker, Robert
    Filipits, Martin
    CLINICAL LUNG CANCER, 2019, 20 (01) : 1 - 6
12345